January 2020
The MPN Community Connection

Educating and Advocating on behalf of those affected by myelofibrosis, 
polycythemia vera, and essential thrombocythemia  

Events

2020

March 5-6
MPN Physicians Summit
San Francisco, CA

May
Brisbane, Australia

August 27
San Antonio, TX

September
Women & MPN Conference
San Francisco, CA

Dates to Be Determined

Washington, DC

The Carolinas

Italy

February Issue

Details on the  March MPN Physicians Summit

In the Trenches:
Physician Story
Patient Story
MPN Support Group Meetings 

January 14 
Idaho

January 28
Pittsburgh, PA

Studying the Benefits of Nutrition

MPNs have some unique concerns when considering dietary/nutrition recommendations, including:
 
Risk of low or high blood counts 

Elevated inflammation
 
Weight gain due to medications 

The effects of nutrition on these symptoms is currently being studied, such as the benefits of following a mediterranean diet. The hope is that altering the balance of inflammation in the body may help individuals to feel better and ultimately change the course of the disease by reducing the risk of blood clots, abnormal blood counts, and spleen size changes.

New Podcast for Blood Cancer

The American Society of Hematology has created a podcast to summarize content recently published in Blood, (the monthly magazine for ASH).

Click the image below to listen to the recent episode on MPNS


Like us on Facebook Follow us on Twitter View our videos on YouTube View on Instagram
Happy New Year! 
Remaining Optimistic for 2020

Since the discovery of the JAK2 gene mutation in 2005, great strides have been made in MPN research and drug development, and a greater understanding of these complex blood cancers has helped all of those affected by MPNs. 

The American Society of Hematology's (ASH) meeting each December, showcases updates and sheds light on what to expect in the future. Take a moment to view our videos from ASH 2019 to learn more.

Pediatric MPN Updates from ASH

By Nicole Kucine, MD, MS
Weill Cornell Medicine

Four abstracts focused on pediatric myeloproliferative neoplasms (MPNs) were presented at the annual ASH meeting in December 2019. It may not seem like a lot, but for pediatric MPNs, it's a big deal!

Above, Dr. Kucine presents at MPN A&EI's Pediatric and Young Adult Program,  learn more
Our group presented two of those abstracts.The first looked at clinical management and reported a small cohort of 6 children treated with Peginterferon alpha-2a (PEG) with colleagues from other institutions.  Currently in pediatric hematology/oncology, the most commonly used medication to lower blood cell counts in children with MPNs is hydroxyurea. While there is no data that this is unsafe for our youngest MPN patients, there is discussion in the adult MPN field of using interferon upfront in younger adult patients and there is very limited data describing its use in pediatric MPN patients. 
Read more
A Mother's Story: When Your Child is Diagnosed with an MPN

No one can prepare you for a cancer diagnosis of a child. Our daughter was four years old and began to complain about headaches. I assumed it was her eyes and made an appointment with an optometrist. Her sight was perfectly normal. A visit to her pediatrician lasted an hour with little insight, only suggestions to watch her diet, limit TV time and give her lots of water. She rarely watched TV and carried water with her throughout the day. Our diet doesn't include sugar except from fresh fruit and we don't eat boxed or canned food. I wasn't optimistic. 

Eventually, her headaches became more severe and on occasion, similar to migraines. We were sent to a neurologist. He requested blood work after she underwent an MRI. Thankfully, the blood work identified the problem. It was ET or essential thrombocythemia. We had never heard of it and had no idea what this meant for the future. A hematologist became our savior. With the proper diagnosis and medication, our daughter began to feel better, albeit a few side effects from the meds. Read more
Prescription Assistance Program: A partnership that has helped many

I am a 57-year-old black man who is in good physical health except for my MPN. I have been receiving treatment for over 15 years. It has been a trying time but with my faith and my hematologist's guidance, I have been able to maintain a normal life and live to the best of my ability. I have received Interferon treatments, blood transfusions, and several other drugs along with other treatments over the years. Currently, I am taking two medications, Jakafi and Uloric once per day to keep things regulated.  There are not many obstacles for me because I was an athlete prior to my diagnosis, however, I have neuropathy in my feet.  

I had to retire early because of the side effects from my treatments, but it has not been too much of a burden to me or my family. I found out about the PAN Foundation  (Patient Access Network) from one of the nurse practitioners in the office where I receive my treatment. PAN has helped me tremendously by covering a portion of the cost of my medication. It has been a blessing because without their assistance I would not be able to afford my medication. 

The PAN Foundation offers grants of up to $8,500 to individuals living with MPN (Philadelphia Chromosome Negative MPNs) to help reduce their out-of-pocket prescription costs. For information on  a pplying for a grant click here or 
call 1-866-316-7263.